Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2013
06/27/2013WO2013096055A1 Compounds for inhibiting the interaction of bcl2 with binding partners
06/27/2013WO2013096049A1 Compounds for inhibiting the interaction of bcl2 with binding partners
06/27/2013WO2013095275A1 Novel hepatitis c virus inhibitors
06/27/2013WO2013092939A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS
06/27/2013WO2013092500A1 Substituted 4-cyan-3-phenyl-4-(pyridine-3-yl)butanoates, processes for preparation thereof and use thereof as herbicides and plant growth regulators.
06/27/2013US20130165631 Bisaminoethanethiol-targeting ligand conjugates and compositions
06/27/2013US20130165485 Insecticidal compounds
06/27/2013US20130165451 Compounds for inflammation and immune-related uses
06/27/2013US20130165440 JAK1 Inhibitors
06/27/2013US20130165438 Prostaglandin d synthase inhibitory piperidine compounds
06/27/2013US20130165422 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
06/27/2013US20130164259 1,4-substituted piperazine derivatives and methods of use thereof
06/27/2013US20130164258 Antiviral Compounds Composed of Three Aligned Aryl Moieties to Treat Diseases such as Hepatitis C
06/27/2013CA2857257A1 Benzyl sulfonamide derivatives as rorc modulators
06/26/2013EP2606727A1 Compounds with nematicidal activity
06/26/2013EP2606041A2 Compounds and methods for the treatment or prevention of flaviviridae viral infections
06/26/2013EP2606036A1 New compounds
06/26/2013EP2606033A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
06/26/2013EP2605652A1 Diketones and hydroxyketones as catenin signaling pathway activators
06/26/2013EP2041124B1 Pyrazolealkanamide substituted thiophenes as ampa potentiators
06/26/2013CN103180313A 有机电致发光装置 Organic electroluminescent device
06/26/2013CN103180312A Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
06/26/2013CN103180296A Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
06/26/2013CN103180291A Alkoxyimino derivative and pest control agent
06/26/2013CN103172624A Thiophene-containing organic semiconductor material and preparation method thereof and organic electroluminescent device
06/26/2013CN103172623A Preparations and applications of thienyl group-containing pyrazolone derivative and its polymer film
06/26/2013CN103172570A Fungicide n-6-membered fused (hetero) aryl-methylene-n-cycloalkyl carboxamide derivatives
06/26/2013CN102491936B Conjugated compound with yellow-green fluorescence and preparation method and use thereof
06/26/2013CN101643450B Synthesis method for multi substituted 2, 3-dihydro-4(1H)-pyrimidin thionone
06/26/2013CN101426780B Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
06/25/2013US8471019 Quinoid systems as organic semiconductors
06/25/2013US8471014 Process of making gyrase and topoisomerase IV inhibitors
06/25/2013US8470875 Use of parthenolide derivatives as antileukemic and cytotoxic agents
06/25/2013US8470861 Mitochondria-targeted antioxidant prodrugs and methods of use
06/25/2013US8470773 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
06/25/2013CA2725425C Homocysteine synthase inhibitor
06/25/2013CA2524048C Immunosuppressant compounds and compositions
06/25/2013CA2285241C Substituted 3-cyano quinolines
06/20/2013WO2013090929A1 Amino quinoline derivatives inhibitors of hcv
06/20/2013WO2013090550A1 Novel glycoside compounds
06/20/2013WO2013090454A2 Novel glp-1 receptor modulators
06/20/2013WO2013090210A1 Metalloenzyme inhibitor compounds
06/20/2013WO2013089087A1 Photoelectric conversion element and dye-sensitized solar cell
06/20/2013WO2013088898A1 Metal complex dye, photoelectric conversion element, dye-sensitized solar cell, dye solution, and compound
06/20/2013WO2013087805A1 Piperazine derivatives and their use as positive allosteric modulators of mglu5 receptors
06/20/2013WO2013087643A1 1,3,5 -triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof
06/20/2013WO2013057013A3 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
06/20/2013US20130158258 2-aminopyrimidine modulators of the histamine h4 receptor
06/20/2013US20130158076 Methylene Urea Derivatives
06/20/2013US20130158044 Piperazine-substituted benzothiophenes for treatment of mental disorders
06/20/2013US20130158034 Trpm8 antagonists and their use in treatments
06/20/2013US20130158022 Acrylamide Compounds And Use Thereof For Inhibiting Apoptosis
06/20/2013US20130158019 Pyrimidine compounds that inhibit anaplastic lymphoma kinase
06/20/2013US20130158018 Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S
06/20/2013US20130158017 Methods for treating or preventing cancer and neurodegenerative diseases
06/20/2013US20130158015 Dual mechanism inhibitors for the treatment of disease
06/20/2013US20130158003 Heteroaryl compounds and methods of use thereof
06/20/2013US20130157997 Benzimidazole analogues for the treatment or prevention of flavivirus infections
06/20/2013US20130157986 Novel methylenedioxy phenolic compounds and their use to treat disease
06/20/2013US20130156731 Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas
06/20/2013CA2857197A1 Novel glp-1 receptor modulators
06/19/2013EP2604656A1 Novel azo compound, aqueous solution, ink composition, ink for inkjet recording, inkjet recording method, ink cartridge for inkjet recording and inkjet recording
06/19/2013EP2604597A1 Heterocyclic compound and use thereof
06/19/2013EP2604595A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
06/19/2013EP2603496A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
06/19/2013EP2603079A1 Positive allosteric modulators of mglur2
06/19/2013CN103159916A Difluoro-benzotriazole based co-polymer organic semiconductor material, and preparation method and application thereof
06/19/2013CN103159733A Thiophene methanamide compound with NDM-1 inhibitory activity
06/19/2013CN103159667A 6-guanidyl-2H-isoindole compound as well as preparation method and application thereof
06/19/2013CN101759814B Single or double functional group thioxanthone and photoinitiator containing same
06/19/2013CN101605764B Fast dissociating dopamine 2 receptor antagonists
06/18/2013USRE44304 Conjugated monomers and polymers and preparation and use thereof
06/18/2013US8466301 Organic dye and dye-sensitized solar cell using the same
06/18/2013CA2595218C Indole derivatives having inhibitory activity against sodium-dependent glucose transporter
06/18/2013CA2566898C Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
06/18/2013CA2566212C Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
06/18/2013CA2560896C Imidazole compounds
06/13/2013WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors
06/13/2013WO2013085957A1 Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors
06/13/2013WO2013085017A1 Pyridone derivative and medicine containing same
06/13/2013WO2013085016A1 Pyridone derivative and medicine containing same
06/13/2013WO2013084138A1 Cyclic urea derivatives as androgen receptor antagonists
06/13/2013WO2013083991A1 Novel compounds and their use in therapy
06/13/2013WO2012177893A3 Trpm8 antagonists and their use in treatments
06/13/2013US20130150424 Proline sulfonamide derivatives as orexin receptor antagonists
06/13/2013US20130150404 Biphenyl derivatives
06/13/2013US20130150374 Arylalkylamine compound and process for preparing the same
06/13/2013US20130150373 Nicotinic receptor compounds
06/13/2013US20130150367 Carboxamide compounds and their use as calpain inhibitors
06/13/2013US20130150358 Theramutein modulators
06/13/2013US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers
06/13/2013US20130150350 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication
06/13/2013US20130150349 2,4-pyrimidinediamine compounds and their uses
06/13/2013US20130150341 Novel compounds
06/13/2013US20130150326 Autotaxin inhibitors and uses thereof
06/13/2013CA2858164A1 Pyridone derivative and medicine containing same
06/12/2013EP2601189A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
06/12/2013EP2600874A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase
06/12/2013EP2475657B1 5-alkinylthien-2-ylcarboxylic acids as inhibitors of flaviviridae viruses
06/12/2013CN103154018A Ligands for antibody and Fc-fusion protein purification by affinity chromatography
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 523